Top > Biopharmaceuticals > Manufacturing
Web Links
Manufacturing
Develops and markets products targeted for treatment of cancer and diseases such as hepatitis B and C, cystic fibrosis and immune system disorders. Based in San Mateo, California. (Nasdaq: SCLN)
Category:
Random Site Quote:
SciClone Pharmaceuticals is a profit-focused, China-centric specialty pharmaceutical company.
is a revenue-generating, China-centric specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases.
© 2011 SciClone Pharmaceuticals, Inc. All rights reserved. Please read our disclaimer.
SciClone
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings
Google PR
Offers novel platforms for the production of protein therapeutics, as well as technology and processes for the purification and formulation. Includes preclinical status of products, and details of corporation in Leiden, The Netherlands.
Category:
Random Site Quote:
Annual General Meeting of Shareholders –
Ruconest for treatment of acute HAE attacks authorized for European Marketing
Pharming develops innovative therapeutics for the treatment of genetic disorders, as well as specialty products for surgical indications, and nutritional products.
Lead product
For detailed information visit the website, please...
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings
Google PR
Offering rDNA derived streptokinase, human interferon alpha of type 2b, and hepatitis-B vaccine, with developments in endocrine, growth factors, immunotherapy, vaccine and diagnostics. Based in Hyderabad, India.
Category:
Random Site Quote:
Shantha adds another feather in its cap by receiving EMEA Certification for cGMP
first Indian company to launch an r-DNA vaccine in 1997, Shantha
heralded a new beginning for biotechnology in India. Shantha
continues to push boundaries and transcend limitations, bolstered
by its research-driven
For detailed information visit the website, please...
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings
Google PR
Company developing small-molecule drugs and recombinant DNA proteins, which regulate gene activity and genetic processes in cancer and other diseases. Includes product information for patients and professionals from San Diego, California. (Nasdaq: LGND)
Category:
Random Site Quote:
Ligand acquired CyDex Pharmaceuticals, a specialty pharmaceutical company based in Lenexa, Kansas. Combined operations effective January 26, 2011. Cydex At-A-Glance • Captisol® Technology
• Five FDA-approved marketed medications
• Drug development efforts with more than 40
For detailed information visit the website, please...
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings
Google PR
Researches and develops proprietary pharmaceutical and diagnostic products based on genes and antibodies. Offers production facilities for therapeutic proteins, and other partnerships in Rockville, Maryland. (Nasdaq: HGSI)
Category:
Random Site Quote:
Human Genome Sciences is an emerging pharmaceutical company with the mission to predict, prevent, detect, treat and cure disease.
March 16, 2011 HUMAN GENOME SCIENCES AND FIVEPRIME THERAPEUTICS ANNOUNCE DEVELOPMENT AND COMMERCIALIZATION AGREEMENT FOR NOVEL ANTI-CANCER DRUG
March 14, 2011 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BARCLAYS CAPITAL CONFERENCE
March 14, 2011 HUMAN GENOME
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings
Google PR
Offers cGMP-grade therapeutic protein production and know-how for candidates through late-stage research, clinical trials and their early industrial lifecycle. Includes overview of stages and contacts in Grenoble France.
Category:
Random Site Quote:
Protein'eXpert is a Contract Research & Manufacturing Organization providing tailor-made target & therapeutic recombinant protein engineering & production services. Our mission is to optimize, produce and deliver R&D-compatible volumes of functional proteins from genomic sequences.
Le contenu de cette page nécessite une version plus récente
PX’Therapeutics is a Contract Research and Manufacturing
Organization dedicated to the development of biotherapeutics from early
stage research up to cGMP production of clinical grade material.
Our areas of expertise
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings
Google PR
Research and clinical trials for alzheimer, stem cell therapy, cancer, and HIV.
Category:
Random Site Quote:
Samaritan Pharmaceuticals, Inc. is an entrepreneurial biopharmaceutical company focused on the development and marketing of innovative therapeutics.
Drug May Restore Memory With
...Caprospinol, actually reversed the course of an Alzheimer-like condition induced in rats. Today, Samaritan Pharmaceuticals, is gearing up for human clinical studies with this compound, also known as SP-233. ...
SAMARITAN PHARMACEUTICALS
Pharmaceuticals, Inc. is an
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings
Google PR
Established manufacturer of drug for treatment of multiple sclerosis, with research focusing on respiratory diseases and congestive heart failure. Offices throughout Europe, Canada with headquarters in Cambridge, Massachusetts.
Category:
Random Site Quote:
Biogen Idec has offices in 28 countries around the world.
“ We need to have new
generation of scientists. ”
We need to have new and fresh perspectives, and that is going to come from the next generation of scientists coming through our Community Lab.
“ Ultimate success will
For detailed information visit the website, please...
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings
Google PR
Developer of a novel class of antibiotics, under license to major manufacturers. Including marketing profile, news archive and contacts in Toronto, Canada.
Category:
Random Site Quote:
TARGETED ANTIBIOTICS FOR SERIOUS INFECTIONS
Affinium is a specialty pharmaceutical company developing a novel class of antibiotics that target the bacterial fatty acid synthesis pathway. AFN-1252, our lead clinical compound, is a highly-potent, small molecule antibiotic for both oral and IV
For detailed information visit the website, please...
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings
Google PR